Medical Product Substitution Supply (Permitted Alternate)

The contract pertains to the supply of an FDA-approved equivalent to Guaifenesin Extended Release identified by substitution identifier RANK 01-00536145188 05H9105, specifically designated for use by the Department of Defense. The product must fully comply with all military packaging and dosage standards established by the Defense Logistics Agency to ensure operational readiness and compatibility with existing medical supply systems. This is a subcontract under the Medical Product Substitution Supply (Permitted Alternate) program, intended to secure an approved alternate formulation that meets stringent quality and regulatory requirements while maintaining therapeutic equivalence. The contract was posted on July 20, 2026, and is governed under NAICS code 325412, which classifies the manufacture of pharmaceutical preparations. Performance and delivery are aligned with Department of Defense logistics protocols, though specific location details for performance or point of contact are not provided in the available data.